Questions about the use of hepatotropic drugs
- Authors: Aydova A.1, Shakirova D.1, Miroshnichenko Y.2, Perfil'ev A.3, Abdulkhakov S.1
-
Affiliations:
- Kazan (Volga region) Federal University
- Saint Petersburg State Chemical and Pharmaceutical University
- Военно-медицинская академия имени С.М. Кирова
- Section: Reviews
- Submitted: 13.03.2026
- Accepted: 11.04.2026
- URL: https://journals.eco-vector.com/RMMArep/article/view/704171
- DOI: https://doi.org/10.17816/rmmar704171
- ID: 704171
Cite item
Abstract
More and more people are striving to take control of their health by independently preventing and treating diseases, including using over-the-counter medications at their own discretion. The implementation of the concept of responsible self-medication opens up opportunities to significantly improve the accessibility and quality of medical care for a significant number of citizens. Pharmaceutical information helps individuals understand the nuances of choosing medications, medical devices, dietary supplements, and other pharmacy products. A pharmaceutical specialist can also provide guidance on the optimal combination of pharmacotherapy and other treatment approaches. In particular, the wide range of hepatotropic drugs, a significant part of which is available without a doctor's prescription, coupled with the lack of evidence-based data on the effectiveness and safety of some of these drugs, and the increasing prevalence of self-medication among the population, further highlights the issue of over-the-counter availability. An analysis of the literature on the evaluation of the effectiveness and safety of hepatotropic drugs reveals an increase in the number of clinical studies conducted on this group of medications, as well as their inclusion in many clinical guidelines for the treatment of liver, gallbladder, and biliary tract diseases. In this regard, there is a need for specific and clear algorithms for pharmaceutical information in the case of over-the-counter dispensing of hepatotropic drugs
Full Text
About the authors
Alina Aydova
Kazan (Volga region) Federal University
Author for correspondence.
Email: ajdova_92@mail.ru
ORCID iD: 0009-0003-9248-3483
SPIN-code: 4327-2673
без степени, ассистент кафедры фармации
Russian Federation, Russia, 420012, The Republic of Tatarstan, Kazan, 76 Karl Marx strDilyara Shakirova
Kazan (Volga region) Federal University
Email: dhabilevna@mail.ru
ORCID iD: 0000-0002-7840-1985
SPIN-code: 1271-6870
докт. фарм. наук, профессор, заведующий кафедрой фармации
Russian Federation, Russia, 420012, The Republic of Tatarstan, Kazan, 76 Karl Marx strYuri Miroshnichenko
Saint Petersburg State Chemical and Pharmaceutical University
Email: miryv61@gmail.com
ORCID iD: 0000-0002-3645-2071
SPIN-code: 9723-1148
доктор фармацевтических наук, профессор, директор института международных образовательных программ ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» МЗ РФ
Russian Federation, Russian Federation, 197376, Saint Petersburg, Professor Popov St., 14, lit. AAlexander Perfil'ev
Военно-медицинская академия имени С.М. Кирова
Email: aborisper@gmail.com
ORCID iD: 0000-0002-9947-1296
SPIN-code: 6843-2803
старший преподаватель кафедры ООМИВ(С)
Russian FederationSayar Abdulkhakov
Kazan (Volga region) Federal University
Email: sayarabdul@yandex.ru
ORCID iD: 0000-0001-9542-3580
SPIN-code: 4131-8360
канд. мед. наук, доцент, заведующий кафедрой внутренних болезней
Russian Federation, Russia, 420012, The Republic of Tatarstan, Kazan, 76 Karl Marx str.References
Supplementary files


